Mississippi FDA - Search News

FDA adds boxed warning to multiple sclerosis drugs

FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since December 1996 and six patient deaths.

Managed Healthcare Executive · 1d

FDA Adds Boxed Warning to MS Drug Copaxone

Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated with the use of Coxapone and the generic Glatopa that have resulted in hospitalization or death.

The American Journal of Manage… · 1d

FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment. Anaphylaxis symptoms can appear within an hour of injection and may lead to severe conditions,

Business Insider · 2d

FDA adds boxed warning to Teva’s Copaxone for allergic reaction

The Food and Drug Administration is adding a boxed warning about the risk of an allergic reaction for Teva‘s (TEVA) Copaxone and Sandoz’s

Becker's Hospital Review · 1d

FDA issues warning on anaphylaxis risk with MS drugs

Symptoms of anaphylaxis typically develop within an hour of injection and can include wheezing, difficulty breathing, swelling of the face or throat and hives. In some cases, the reaction can lead to hospitalization or death.

SCOTUSblog2h

Supreme Court likely to let vape company’s FDA challenge proceed

At oral arguments earlier this week the Supreme Court was skeptical of the Food and Drug Administration’s effort to block a North Carolina-based company from challenging the denial of its application ...

Hosted on MSN5d

Mississippi Insight for Jan. 19, 2025: Dortch and Latino

Jarvis Dortch with the ACLU of Mississippi discusses legislative redistricting, while Magnolia Tribune's Russ Latino examines ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA adds boxed warning to multiple sclerosis drugs

Trending now